News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Becton, Dickinson and Company (BDX) False Advertising and Antitrust Lawsuit Heads to Trial


8/23/2013 8:10:48 AM

free biotech news Get the latest biotech news where 

you want it. Sign up for the free GenePool newsletter today!

A Texas judge permits Retractable Technologies Inc. to proceed with a lawsuit accusing rival Becton Dickinson of false advertising and violations of antitrust laws. Becton Dickinson & Co. (NYSE:BDX) is headed to court next month to speak to allegations, brought by rival Retractable Technologies' (NYSE:RVP), that it engaged in illegal in order to maintain a monopoly in the syringe business. A Texas federal judge dismissed Becton's motion for summary judgment, ruling that there is sufficient evidence "suggesting that [Becton’s] contracts have anticompetitive effects," Law360.com reported.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES